https://www.selleckchem.com/pr....oducts/importazole.h
0%, p=0.02). SCF was not significantly altered. The effects of both drugs did not differ significantly. Loss of SM occurred early on during treatment with ENZA. Treatment with ENZA seems to lead to a loss of SM which is comparable to that of ABI. Further evaluation in larger patient-cohorts is warranted. In routine care, counselling of patients about side effects of ABI/ENZA should include discussions about SM loss. Treatment with ENZA seems to lead to a loss of SM which is comparable to that of ABI. Further evaluation in larger pat
Like
Comment
Share
